SinoMab BioScience Limited

About Us

Science, Innovation and Technology

Product and Product Pipeline

Partnership

Investor Relations

News Centre

Sustainability

Careers

Contact Us

Company Overview Milestones Board of Directors Management Team Directors of Subsidiaries Corporate Governance

Technology Platform Research Areas Scientific Publications Production Base

Product Pipeline Clinical Trials

Strategic Partnering Events and Conferences Contact

Corporate Information Financial Highlights Announcement and Circular Financial Reports Share Prices Investor Calendar Email Alert Announcement - Replacement of Lost Share Certificates Dissemination of Corporate Communications Investor Inquiries

Corporate News Press Release Media Enquiries

ESG Reports

Job Opportunities Company Culture

繁

简

scroll

We become:

A leading global
biopharmaceutical company
for the development
of novel drugs

Company Overview
We care:

Improve Quality of Life

Product and Product Pipeline
We believe:

Innovation Knows No Bounds

Science, Innovation and Technology

About Us

First Hong Kong home-grown biopharmaceutical company listed on the Hong Kong Stock Exchange

Headquarters and R&D base in Hong Kong with production base in China; dedicated to the research, development, manufacturing and commercialization of therapeutics that address unmet medical needs for patients with immunological diseases.

Learn More

3681.HK

SinoMab BioScience Limited Quote delayed at least 15 minutes

[Disclaimer]

This is a 15-minute delayed quotation. It will not guarantee its absolute accuracy and reliability, and will not be liable for any loss or damage caused by any inaccuracies or omissions (regardless of whether it is a liability under tort law or contractual liability. Or other responsibilities)

HKD

Open

Previous Close

Market Cap